Huge Growth Expected in 3D Bioprinting Market in Future


Posted May 11, 2022 by PSMarketResearch12

According to the estimates of the market research company, P&S Intelligence, the 3D bioprinting market will demonstrate a CAGR of 35.9% from 2016 to 2022 (forecast period).
 
The market is being driven by the burgeoning requirement for tissue and organ transplants, increasing need for compliance with drug discovery standards, and the rapid advancements being made in medical technology across the world.

3D bioprinting provides platforms that can be used for drug discovery and drug development. The tissues produced via 3D bioprinting assist in improving drug efficacy. Moreover, the use of 3D bioprinting has also caused a sharp reduction in the time taken for clinical trials. In recent times, many 3D bioprinting companies and pharmaceutical organizations have announced collaborations with each other for testing drugs at the initial phase of drug development. Furthermore, many pharmaceutical organizations have initiated the testing of new drugs developed on 3D printing tissues, which is assisting them in expediting the drug discovery process.

Out of these, the tissue and organ regeneration category dominated the 3D bioprinting market in the years gone by, and this trend is predicted to continue in the forthcoming years as well. On the other hand, the 3D cell culture category is predicted to exhibit the fastest growth in the market in the coming years. This will be because of the increasing R&D activities that are being carried out in the domain of stem cell research all over the world.

Globally, North America is predicted to contribute the highest revenue to the 3D bioprinting market throughout the forecast period. This is credited to the presence of well-developed healthcare infrastructure, rapid technological advancements, and the existence of major market players in the region. In addition, the surging population of geriatric people and the rising incidence of chronic diseases are also driving the growth of the market in the continent. The U.S. is predicted to hold the majority shares in the market in the future, primarily because of the surging R&D activities that are being carried out in the field of tissue engineering in the country.

Thus, it is clear that the demand for 3D bioprinting will skyrocket in the coming years, owing to the rising requirement for tissue and organ transplants, rapid technological advancements in the healthcare sector, and the growing incidence of chronic diseases across the world.

Browse In-depth 3D Bioprinting Market Growth Forecast Report @ https://www.psmarketresearch.com/market-analysis/3d-bioprinting-market
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Pramod Kmr
Country United States
Categories Biotech , Reports , Research
Tags 3d bioprinting market , 3d bioprinting market research report , 3d bioprinting market share , 3d bioprinting market size , 3d bioprinting market trends
Last Updated May 11, 2022